Table 2 Univariate regression analysis
Label | Levels | Negative | Positive | OR (univariable) |
|---|---|---|---|---|
Gender | Female | 62 (58.5) | 44 (41.5) | – |
|  | Male | 90 (77.6) | 26 (22.4) | 0.41 (0.23–0.72, p = 0.003) |
Age (years) | Mean (SD) | 62.3 (16.1) | 75.0 (12.3) | 1.07 (1.04–1.10, p < 0.001) |
Presumed causes | Odontogenic infection | 136 (84.0) | 26 (16.0) | – |
|  | Dental extraction | 5 (15.6) | 27 (84.4) | 28.25 (10.74–89.57, p < 0.001) |
|  | Implant | 3 (30.0) | 7 (70.0) | 12.21 (3.17–59.54, p = 0.001) |
|  | Unknown | 8 (44.4) | 10 (55.6) | 6.54 (2.37–18.68, p < 0.001) |
Anatomical site | Maxilla posterior | 40 (69.0) | 18 (31.0) | – |
|  | Maxilla anterior | 9 (69.2) | 4 (30.8) | 0.99 (0.24–3.48, p = 0.985) |
|  | Mandible posterior | 99 (70.2) | 42 (29.8) | 0.94 (0.49–1.86, p = 0.862) |
|  | Mandible anterior | 4 (40.0) | 6 (60.0) | 3.33 (0.85–14.45, p = 0.088) |
Comorbidities | Hypertension | 68 (60.2) | 45 (39.8) | 2.22 (1.25–4.03, p = 0.007) |
|  | Diabetes mellitus | 40 (67.8) | 19 (32.2) | 1.04 (0.54–1.96, p = 0.897) |
|  | Heart disease | 35 (71.4) | 14 (28.6) | 0.84 (0.41–1.65, p = 0.614) |
|  | Renal disease | 18 (72.0) | 7 (28.0) | 0.83 (0.31–2.01, p = 0.687) |
|  | Liver disease | 9 (90.0) | 1 (10.0) | 0.23 (0.01–1.26, p = 0.168) |
|  | Cerebral disease | 13 (92.9) | 1 (7.1) | 0.15 (0.01–0.80, p = 0.075) |
|  | Malignancy | 7 (41.2) | 10 (58.8) | 3.45 (1.27–9.91, p = 0.016) |
|  | Rheumatoid arthritis | 1 (20.0) | 4 (80.0) | 9.15 (1.32–180.87, p = 0.050) |
Antiresorptive agents |  | 16 (28.1) | 41 (71.9) | 12.02 (6.07–24.89, p < 0.001) |
Antithrombotic agents |  | 44 (63.8) | 25 (36.2) | 1.36 (0.74–2.48, p = 0.312) |